Easywell Biomedicals Bilan de santé
Santé financière contrôle des critères 6/6
Easywell Biomedicals has a total shareholder equity of NT$745.2M and total debt of NT$44.5M, which brings its debt-to-equity ratio to 6%. Its total assets and total liabilities are NT$1.4B and NT$653.8M respectively.
Informations clés
6.0%
Ratio d'endettement
NT$44.45m
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | NT$433.19m |
| Fonds propres | NT$745.19m |
| Total du passif | NT$653.80m |
| Total des actifs | NT$1.40b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Analyse de la situation financière
Passif à court terme: 1799's short term assets (NT$676.7M) exceed its short term liabilities (NT$168.3M).
Passif à long terme: 1799's short term assets (NT$676.7M) exceed its long term liabilities (NT$485.5M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 1799 has more cash than its total debt.
Réduire la dette: 1799's debt to equity ratio has reduced from 13.5% to 6% over the past 5 years.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: 1799 has sufficient cash runway for more than a year based on its current free cash flow.
Prévisions de trésorerie: 1799 has sufficient cash runway for 1.4 years if free cash flow continues to grow at historical rates of 15.1% each year.